Correlation Between Centessa Pharmaceuticals and Ardelyx
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and Ardelyx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and Ardelyx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and Ardelyx, you can compare the effects of market volatilities on Centessa Pharmaceuticals and Ardelyx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of Ardelyx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and Ardelyx.
Diversification Opportunities for Centessa Pharmaceuticals and Ardelyx
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Centessa and Ardelyx is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and Ardelyx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ardelyx and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with Ardelyx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ardelyx has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and Ardelyx go up and down completely randomly.
Pair Corralation between Centessa Pharmaceuticals and Ardelyx
Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to generate 0.9 times more return on investment than Ardelyx. However, Centessa Pharmaceuticals PLC is 1.11 times less risky than Ardelyx. It trades about 0.11 of its potential returns per unit of risk. Ardelyx is currently generating about 0.02 per unit of risk. If you would invest 1,350 in Centessa Pharmaceuticals PLC on September 3, 2024 and sell it today you would earn a total of 345.00 from holding Centessa Pharmaceuticals PLC or generate 25.56% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Centessa Pharmaceuticals PLC vs. Ardelyx
Performance |
Timeline |
Centessa Pharmaceuticals |
Ardelyx |
Centessa Pharmaceuticals and Ardelyx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Centessa Pharmaceuticals and Ardelyx
The main advantage of trading using opposite Centessa Pharmaceuticals and Ardelyx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, Ardelyx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ardelyx will offset losses from the drop in Ardelyx's long position.The idea behind Centessa Pharmaceuticals PLC and Ardelyx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Ardelyx vs. BioLineRx | Ardelyx vs. Lexicon Pharmaceuticals | Ardelyx vs. Seres Therapeutics | Ardelyx vs. Immunitybio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Global Correlations Find global opportunities by holding instruments from different markets |